Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Topical Interleukin-1-Receptor Antagonist in the Treatment of Signs and Symptoms of Posterior Blepharitis

NCT00681109 is registered in ClinicalTrials.gov with Reza Dana, MD as lead sponsor.

NCT NCT00681109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00681109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Topical Interleukin-1-Receptor Antagonist in the Treatment of Signs and Symptoms of Posterior Blepharitis
Lead sponsor
Reza Dana, MD
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2008
Completion date
October 31, 2010
Enrollment
75 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

posterior blepharitis